Amendment No. 3 to the 2002 Agreement between Discovery Partners International, Inc and Pfizer IncAmendment No. 3 to the 2002 Agreement • March 21st, 2003 • Discovery Partners International Inc • Services-commercial physical & biological research
Contract Type FiledMarch 21st, 2003 Company IndustryExecution of this letter amendment (“Amendment No. 3”) between Pfizer Inc (“Pfizer”) and Discovery Partners International, Inc. (“DPI”), will serve to amend an agreement between the parties, effective as of January 5, 2002 (the “2002 Agreement”) as amended on June 20 and August 13, 2002 (such amendments being, respectively, “Amendment No. 1” and “Amendment No. 2” and, together with the 2002 Agreement, the “Agreement”).